LPT
CLVS

Legacy Private Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

Legacy Private Trust’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,000
Closed -$211K – 234
2018
Q1 		$211K Hold
4,000
– – 0.02% 225
2017
Q4 		$272K Hold
4,000
– – 0.03% 203
2017
Q3 		$330K Hold
4,000
– – 0.04% 195
2017
Q2 		$375K Hold
4,000
– – 0.05% 185
2017
Q1 		$255K Buy
+4,000
New +$243K 0.03% 218

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

Legacy Private Trust's CLVS Position: Q2 2018 in Review

Legacy Private Trust sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 4,000 shares — an estimated $211K sold.

Legacy Private Trust first reported a position in CLVS in Q1 2017 and held it in 5 quarters. The position peaked at $375K in Q2 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • Legacy Private Trust reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
  • Legacy Private Trust sold 4,000 Clovis Oncology, Inc. shares in Q2 2018, an estimated $211K.
  • Legacy Private Trust first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 5 quarters.
  • Legacy Private Trust's Clovis Oncology, Inc. position peaked at $375K in Q2 2017.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Legacy Private Trust's 13F filing for Q2 2018, filed 13 Jul 2018.